Job Description
The Director, Supply Chain Value Analysis leads the evaluation, selection, and optimization of clinical products,
medical devices, and purchased services to ensure they deliver clinical, financial, and operational value to the
health system. This role oversees product review governance, partners closely with physicians and clinicians,
and collaborates with supply chain sourcing and finance teams. The director drives cost savings, standardization,
and quality improvement initiatives that support organizational goals. The Director, Supply Chain Value Analysis
leads a team responsible for evaluating clinical products, technologies, and supplies to determine clinical,
financial, and operational value across the health system. This transformation role will evolve a matrixed team
structure to fully leverage our shared service across multiple clinical service lines. Initially focused on high value
physician preference items, the role will drive value by mobilizing clinical teams to drive standardization of
clinical practice.
The Director will report directly to the health system VP/Chief Supplier Chain Officer and will work very closely
with the shared service strategic sourcing and purchasing team.
Primary Duties and Responsibilities:
Leads the systemwide value analysis function by directing enterprise processes for product evaluation,
technology review, and clinical request assessment, supporting harmonized decision‑making across service
lines and care settings in alignment with executive strategy and governance. Oversees product evaluations,
technology reviews, and clinical request assessments.
performance, patient safety, patient experience, EPS impact, and operational considerations, enabling
informed, data‑driven decisions by executive and clinical leadership.
and physicians to promote alignment, transparency, and shared accountability for decisions across service
lines and care settings.
contracting strategies, supporting vendor alignment, product rationalization, and cost optimization across
clinical and non‑clinical categories.
of ownership analyses, business cases, and post‑implementation evaluations, to support enterprise financial
targets and performance monitoring.
with clinical and operational leaders, supporting systemwide value optimization while respecting clinical
autonomy and governance structures.
requirements.
transitions, utilization alignment, and enterprise value objectives through data, evidence, and
consensus‑building.
metrics, providing summarized insights to executive leadership to support enterprise financial performance
evaluation.
logs, and audit records, to ensure transparency, traceability, and adherence to approved governance
processes.
partnering with operational, clinical, and executive leaders to support adoption, minimize disruption, and
sustain outcomes across care settings.
process optimization, and capability maturity, ensuring alignment with organizational strategy and executive
priorities.
Qualifications
minimum Bachelor's Degree - Healthcare management, nursing, business, or related field
preferred Master's Degree - Healthcare management, nursing, business, or related field
8 years minimum - Healthcare supply chain, value analysis, clinical operations, or comparable experience.
6 years minimum - Clinical workflows, product evaluation processes, and healthcare financial models.
8 years minimum - Working closely with physicians on product or clinical decision-making
3 years minimum - Staff leadership experience such as supervisor, or manager
4 years minimum - Leading cross functional transformation initiatives
3 years minimum - Leading cost-reduction and standardization initiatives
This hybrid role requires minimum 1 day per week on site - on site can be at various locations across the health systems and may vary.
Cedars Sinai is one of the largest nonprofit academic medical centers in the United States, and it is the largest private academic medical center in the Western United States. The Cedars Sinai main campus, which encompasses nearly 24 acres, is located at the point where the cities of Los Angeles, Beverly Hills, and West Hollywood meet. Cedars Sinai has been recognized annually by U.S. News & World Report’s top 10 best hospitals in the U.S. The institution most recently placed No. 7 among a select group of 20 Honor Roll hospitals and ranked nationally in a dozen specialties. In addition, Cedars Sinai ranked No. 3 in California and No. 2 in the Los Angeles metro area.
Within Cedars Sinai, the Institute for Research on Health Aging conducts multi-disciplinary research that prioritizes the prevention of cardiovascular disease, neurocognitive disease, and cancer. Our focus is on translating new research discoveries into pragmatic interventions aimed at promoting healthy aging across diverse populations. Our approach involves human physiology, cohort, and clinical trial studies and our team includes established experts in population, clinical, translational, basic, and data science.